Page last updated: 2024-08-21

isoxazoles and cyc 202

isoxazoles has been researched along with cyc 202 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cory, AH; Cory, JG; Edwards, CC; Hall, JG	1

Other Studies

1 other study(ies) available for isoxazoles and cyc 202

Article	Year
Inhibitors of diverse metabolic steps cause increased apoptosis in deoxyadenosine-resistant mouse leukemia L1210 cells that lack p53 expression: convergence at caspase-3 activation. Advances in enzyme regulation, 2003, Volume: 43 Topics: Androstadienes; Animals; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butyrates; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Coloring Agents; Deoxyadenosines; DNA Damage; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Genistein; Isoxazoles; Leflunomide; Mice; Models, Biological; Purines; RNA, Messenger; Roscovitine; Sesquiterpenes; Time Factors; Tumor Suppressor Protein p53; Wortmannin	2003

Article

Year

Inhibitors of diverse metabolic steps cause increased apoptosis in deoxyadenosine-resistant mouse leukemia L1210 cells that lack p53 expression: convergence at caspase-3 activation.

Advances in enzyme regulation, 2003, Volume: 43

Topics: Androstadienes; Animals; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butyrates; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Coloring Agents; Deoxyadenosines; DNA Damage; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Genistein; Isoxazoles; Leflunomide; Mice; Models, Biological; Purines; RNA, Messenger; Roscovitine; Sesquiterpenes; Time Factors; Tumor Suppressor Protein p53; Wortmannin

2003